Literature DB >> 24446432

Clinical relevance of frozen diagnosis of ductal margins in surgery of bile duct cancer.

Toru Furukawa1, Ryota Higuchi, Masakazu Yamamoto.   

Abstract

It is anticipated that free surgical margin is crucial for curative resection of bile duct cancer. However, the clinical relevance of the ductal margin is somewhat controversial. A role of frozen section diagnosis used for evaluation of the ductal margin during surgery is also ambiguous. We reviewed the current knowledge about frozen section diagnosis and the clinical relevance of the margin status in surgery of the bile duct cancer. Frozen section diagnosis of the ductal margin of bile duct cancer is necessary to ensure free margins; however, it is quite challenging even for experienced pathologists because the bile duct involved with bile duct cancer is often inflamed severely due to obstruction and/or insertion of a draining tube, which induces epithelial regeneration with atypia. Also accessory ducts/peribiliary glands and their conduits in ductal wall can mimic invasive ductal components, which requires careful examination to evaluate regenerative change, carcinoma in situ, or invasive carcinoma. Published studies assessing an association between the ductal margin state and prognosis in relatively large cohorts of patients undergoing surgery for bile duct cancer indicate that the ductal margin status is an independent prognostic factor; and the ductal margin with carcinoma in situ is comparable to free margin; however, the margin with invasive carcinoma is significantly adverse for patients' prognoses.
© 2014 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Bile duct cancer; Carcinoma in situ; Invasive carcinoma; Margin; Prognosis

Mesh:

Year:  2014        PMID: 24446432     DOI: 10.1002/jhbp.73

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  8 in total

1.  Relationship between the surgical margin status, prognosis, and recurrence in extrahepatic bile duct cancer patients.

Authors:  Hiroshi Kurahara; Kosei Maemura; Yuko Mataki; Masahiko Sakoda; Satoshi Iino; Yota Kawasaki; Shinichiro Mori; Yuko Kijima; Shinichi Ueno; Hiroyuki Shinchi; Sonshin Takao; Shoji Natsugoe
Journal:  Langenbecks Arch Surg       Date:  2016-08-05       Impact factor: 3.445

2.  Preliminary results in unresectable cholangiocarcinoma treated by CT percutaneous irreversible electroporation: feasibility, safety and efficacy.

Authors:  Maria Paola Belfiore; Alfonso Reginelli; Nicola Maggialetti; Mattia Carbone; Sabrina Giovine; Antonella Laporta; Fabrizio Urraro; Valerio Nardone; Roberta Grassi; Salvatore Cappabianca; Luca Brunese
Journal:  Med Oncol       Date:  2020-04-09       Impact factor: 3.064

3.  Indication of extrahepatic bile duct resection for gallbladder cancer.

Authors:  Hiroshi Kurahara; Kosei Maemura; Yuko Mataki; Masahiko Sakoda; Satoshi Iino; Yota Kawasaki; Shinichiro Mori; Takaaki Arigami; Yuko Kijima; Hiroyuki Shinchi; Shoji Natsugoe
Journal:  Langenbecks Arch Surg       Date:  2017-09-05       Impact factor: 3.445

Review 4.  Surgical management of carcinoma in situ at ductal resection margins in patients with extrahepatic cholangiocarcinoma.

Authors:  Toshifumi Wakai; Jun Sakata; Tomohiro Katada; Yuki Hirose; Daiki Soma; Pankaj Prasoon; Kohei Miura; Takashi Kobayashi
Journal:  Ann Gastroenterol Surg       Date:  2018-07-26

5.  Nonanatomic resection is not inferior to anatomic resection for primary intrahepatic cholangiocarcinoma: A propensity score analysis.

Authors:  B Li; J L Song; Y Aierken; Y Chen; J L Zheng; J Y Yang
Journal:  Sci Rep       Date:  2018-12-12       Impact factor: 4.379

6.  Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma.

Authors:  Dingzhong Peng; Jiong Lu; Haijie Hu; Bei Li; Xiwen Ye; Nansheng Cheng
Journal:  J Gastrointest Surg       Date:  2019-01-22       Impact factor: 3.452

7.  A simple scoring system to predict early recurrence of Bismuth-Corlette type IV perihilar cholangiocarcinoma.

Authors:  Ding-Zhong Peng; Jiong Lu; Bei Li; Hai-Jie Hu; Xi-Wen Ye; Xian-Ze Xiong; Nan-Sheng Cheng
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-04-21

8.  The Impact of Intraoperative Frozen Section on Resection Margin Status and Survival of Patients Underwent Pancreatoduodenectomy for Distal Cholangiocarcinoma.

Authors:  Zhiqiang Chen; Bingran Yu; Jiaping Bai; Qiong Li; Bowen Xu; Zhaoru Dong; Xuting Zhi; Tao Li
Journal:  Front Oncol       Date:  2021-05-03       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.